MTOR (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "MTOR" in German language version.

refsWebsite
Global rank German rank
4th place
7th place
2nd place
3rd place
3,043rd place
200th place
2,374th place
1,391st place
123rd place
6th place
low place
low place
low place
low place
5,293rd place
8,650th place
low place
low place

aerzteblatt.de

  • G. Blaeser-Kiel: Sirolimus zum Transplantatschutz. Bessere Langzeitprognose durch geringere Tumorinzidenz. In: Deutsches Ärzteblatt. Nr. 104, 2007, S. A-1255 (Artikel).
  • W. Kühn, G. Walz: Autosomal dominante polyzystische Nierenerkrankung. In: Dtsch Arztebl. Band 104, Nr. 44, 2007, S. 3022–3028 (Artikel).

doi.org

genesdev.org

  • N. Hay, N. Sonenberg: Upstream and downstream of mTOR. In: Genes Dev. Nr. 18, 2004, S. 1926–1945 (Artikel). PMID 15314020

jci.org

  • Ushma S. Neill: A conversation with Michael Hall. In: Journal of Clinical Investigation. Band 127, Nr. 11, 1. November 2017, ISSN 0021-9738, S. 3916–3917, doi:10.1172/JCI97760 (jci.org [abgerufen am 23. Mai 2023]).

landesbioscience.com

  • Janet E. Dancey: MTOR and Related Pathways. In: Cancer Biology & Therapy. Nr. 5, 2006, S. 1065–1073 (PDF).

nejm.org

content.nejm.org

  • Henrik Ekberg et al.: Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation. In: N Engl J Med. Nr. 357, 2007, S. 2561–2575 (Abstract).
  • John J. Bissler et al.: Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis. In: N Engl J Med. Nr. 358, 2008, S. 140–151 (Abstract).

nih.gov

ncbi.nlm.nih.gov

  • J. Heitman, N. R. Movva, M. N. Hall: Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. In: Science. Nr. 253, 1991, S. 905–909, PMID 1715094.
  • N. Hay, N. Sonenberg: Upstream and downstream of mTOR. In: Genes Dev. Nr. 18, 2004, S. 1926–1945 (Artikel). PMID 15314020
  • R. Loewith et al.: Two TOR Complexes, Only One of which Is Rapamycin Sensitive, Have Distinct Roles in Cell Growth Control. In: Molecular Cell. Band 10, Nr. 3, 2002, S. 457–468, PMID 12408816.
  • Gary Hudes et al.: Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. In: N Engl J Med. Nr. 356, 2007, S. 2271–2281, PMID 17538086.
  • Wilfred Lieberthal, Jerrold S Levine: The role of the mammalian target of rapamycin (mTOR) in renal disease. In: Journal of the American Society of Nephrology. Band 20, Nr. 12, Dezember 2009, S. 2493–2502, doi:10.1681/ASN.2008111186, PMID 19875810.

physiology.org

physiologyonline.physiology.org

  • Xuemin Wang, Christopher G. Proud: The mTOR Pathway in the Control of Protein Synthesis. In: Physiology. Nr. 21, 2006, S. 362–369 (Artikel).

zdb-katalog.de

  • Ushma S. Neill: A conversation with Michael Hall. In: Journal of Clinical Investigation. Band 127, Nr. 11, 1. November 2017, ISSN 0021-9738, S. 3916–3917, doi:10.1172/JCI97760 (jci.org [abgerufen am 23. Mai 2023]).